about
Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-makingThe complex evolution of antibiotic resistance in Mycobacterium tuberculosisA Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant TuberculosisCost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions.Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countriesPredicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis.Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.Tuberculosis prevention in South AfricaThe Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.Methods for estimating the burden of antimicrobial resistance: a systematic literature review protocol.Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.The transmission of Mycobacterium tuberculosis in high burden settings.Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis.Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.Within-host diversity of MRSA antimicrobial resistances.Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network.Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose.Ebola: the power of behaviour change.Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time.Large mobile genetic elements carrying resistance genes that do not confer a fitness burden in healthcare-associated meticillin-resistant Staphylococcus aureus.Conditions for global dynamic stability of a class of resource-bounded model ecosystems.Potential impact of influenza vaccine roll-out on antibiotic use in Africa.The relative fitness of drug-resistant : a modelling study of household transmission in PeruUsing vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-makingQuantifying where human acquisition of antibiotic resistance occurs: a mathematical modelling studyFast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitalsThe importance of cross-disciplinary research to combat antimicrobial resistance: introducing a new pop-up journal, X-AMRMathematical modelling for antibiotic resistance control policy: do we know enough?Mathematical modelling to study the horizontal transfer of antimicrobial resistance genes in bacteria: current state of the field and recommendationsCOVID-19 length of hospital stay: a systematic review and data synthesis
P50
Q26778619-2B8B7A8E-E0C2-4C78-B7A5-4B2B4D91EE56Q28081874-1F04CC24-50D7-423C-8834-9A27F1032097Q29048653-5A278EBE-62C9-4D47-89BE-7E153B9B30D7Q30830344-59DD4363-6E28-4EB0-ACC0-BEDD68D52441Q31141086-2190B53B-3338-467E-B7C9-D8F87670BC6CQ31154267-9187A0CE-0490-41C2-B0A5-1D7DB9F0626EQ34441930-BCBF9EB8-FACD-46BE-AD08-68D1A5CD280AQ34999621-03D2962E-9470-4616-BB3D-37D022F1D795Q35166484-35B0985A-9A78-49CD-83E3-22D82EE9C7CFQ35304473-F59FC0E6-6D50-4A73-AA7E-070A95713C12Q35881727-204C761E-11B8-4B38-BCEB-D6F73064E7A7Q36094198-71F96646-D72F-4303-952A-6BC658AB526FQ37400757-391B8970-D04D-408D-8FA1-8AC436CCBAA1Q37473293-6CDC9AA8-3955-48CB-900C-F22529646F1AQ38729690-7E03FC1A-113C-427D-BEBF-A74DAC19ABFFQ39033548-F8E50D29-8D0E-4ACC-BE9C-4F9593352721Q39395640-20790700-3CA8-44BB-99D3-2E02E51A2F93Q39486042-8DD32AAA-DB14-43A7-B1D9-F34054AA4F1BQ40664938-9FF17A94-31AC-4B30-B9BE-F95FD5C99EE5Q42575812-AA3C544C-09EC-49E8-818E-8A4560DF518BQ43739615-0C772C31-9B58-433D-9B0A-2AD929543AB5Q44593794-D790AF5F-AA84-4744-BB2B-C62460C1C45CQ44741757-FD793BB4-6057-43A7-BBCF-A234AEC6AA73Q51717182-52F6C3BF-62A2-4E5C-ABF5-6163C5818937Q54215595-23BAEA3E-EEEE-4067-9EF3-552DE06766FEQ56895151-DD4D8E37-9B0E-4844-97C5-2A5F58C220E7Q58375482-9CED4704-2FE7-481C-A18D-FB6B5B884180Q58716126-53417E14-20C8-4878-B8AF-8569DC0D32C2Q58775356-988218A9-9FC5-4F17-B49F-CC2FC2E7D014Q60335619-425B9720-91CB-44EA-AB52-F22FCF106907Q91553350-5FE63AB3-40EC-483E-B782-22E31AB512BDQ92598588-58ED8B20-77D3-4C21-8FFC-A5E59C95E95CQ95607562-96CEF422-DD64-4DE9-916D-FE31B1B2DA83
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-7263-9896
@en
name
Gwenan M Knight
@ast
Gwenan M Knight
@en
Gwenan M Knight
@es
Gwenan M Knight
@nl
type
label
Gwenan M Knight
@ast
Gwenan M Knight
@en
Gwenan M Knight
@es
Gwenan M Knight
@nl
prefLabel
Gwenan M Knight
@ast
Gwenan M Knight
@en
Gwenan M Knight
@es
Gwenan M Knight
@nl
P106
P1153
37034264200
P21
P31
P496
0000-0002-7263-9896